. Dans-ce-cas,-la-patiente-Était-traitée-À-une-posologie-trop-importante, En effet, selon le RCP de Motilium® (Annexe B), la posologie maximum recommandée est de 30 mg par jour

M. Boyce, K. Baisley, and S. Warrington, Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study, British Journal of Clinical Pharmacology, vol.96, issue.3, pp.73-411
DOI : 10.1007/s00246-004-0922-z

H. Chen, Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythm ia: a nationwide case?crossover study, Pharmacoepidemiol Drug Saf, 2015.
DOI : 10.1002/pds.3814

S. Claassen and B. Zünkler, Comparison of the Effects of Metoclopramide and Domperidone on HERG Channels, Pharmacology, vol.19, issue.1, pp.31-37, 2005.
DOI : 10.1046/j.1365-2036.2003.01641.x

F. De-loose, Double-blind comparison of domperidone with placebo in the treatment of chronic postprandial gastrointestinal distress: A multicenter study, Clinical Research Report, 1980.

O. Dhakal, M. Dhakal, D. Bhandari, and . Domperidone, Domperidone-induced dystonia: a rare and troublesome complication, Case Reports, vol.24, issue.jun27 1, p.27, 2014.
DOI : 10.18773/austprescr.2001.011

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078522/pdf

J. K. Dibaise, Esophagus and stomach Nausea and Vomiting. Practical gastroenterology and hepatology, 2010.

D. Djeddi, G. Kongolo, C. Lefaix, J. Mounard, and A. Léké, Effect of Domperidone on QT Interval in Neonates The Journal of Pediatrics, pp.663-666, 2008.

. Drolet, G. Rousseau, P. Daleau, R. Cardinal, and J. Turgeon, Domperidone Should Not Be Considered a No-Risk Alternative to Cisapride in the Treatment of Gastrointestinal Motility Disorders, Circulation, vol.102, issue.16, pp.1883-1888, 2000.
DOI : 10.1161/01.CIR.102.16.1883

E. Prac, List of questions to be addressed by the marketing authorisation holder(s) for domperidone containing medicinal products, 2013.

W. Englert and D. Schlich, A double-blind crossover trial of domperidone in chronic postprandial dyspepsia, Postgrad Med J, vol.55, pp.28-29, 1979.

P. Fais, A case of sudden cardiac death following Domperidone self-medication, Forensic Science International, vol.254, pp.1-3, 2015.
DOI : 10.1016/j.forsciint.2015.06.004

A. Gunlemez, A. Babaoglu, and A. Arisoy, Effect of domperidone on the QTc interval in premature infants, Journal of Perinatology, vol.53, issue.1, 2009.
DOI : 10.1016/j.jpeds.2008.05.013

L. Hondeghem, Domperidone, Journal of Cardiovascular Pharmacology, vol.61, issue.3, pp.218-243, 2013.
DOI : 10.1097/FJC.0b013e31827afd0d

C. Johannes, C. Varas-lorenzo, L. Mcquay, K. Midkiff, and D. Fife, Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study, Pharmacoepidemiology and Drug Safety, vol.41, issue.9, pp.881-889, 2010.
DOI : 10.1002/pds.2016

L. Kailas, S. Sugunan, G. Bindu, C. Thomas, and . Domperidone, Neuroleptic malignant syndrome: case report]. A Case of Neuroleptic Malignant Syndrome in an Infant, Indian Journal of Pediatrics, vol.81, issue.10, pp.3-1115, 2014.

L. Jansen, Dear Doctor Letter regarding Domperidone publiée le 06-DEC, 2011.

. Lareb, Netherlands Pharmacovigilance Cntr) Domperidone. Overview of reports of cardiac adverse drug reactions associated with domperidone, Lareb Quarterly Report, issue.3, pp.29-34, 2013.

N. Leelakanok, Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death

A. Systematic and R. , Clinical drug investigation

J. Montastruc, H. Bagheri, and J. M. Senard, Syndrome malin des neuroleptiques et syndrome sérotoninergique : diagnostics positifs et différentiels et étiologies médicamenteuses, 2000.

A. Ortiz, Cardiovascular Safety Profile and Clinical Experience With High-Dose Domperidone Therapy for Nausea and Vomiting, The American Journal of the Medical Sciences, vol.349, issue.5, pp.421-424, 2015.
DOI : 10.1097/MAJ.0000000000000439

S. Renoux, P. Dell-'aniello, C. Khairy, S. Marras, T. Bugden et al., Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease, British Journal of Clinical Pharmacology, vol.44, issue.2, pp.461-472, 2016.
DOI : 10.1016/j.jacc.2004.06.029

C. Wolfson and R. Postuma, Restless legs syndrome outside the blood-brain barrier-exacerbation by domperidone in Parkinson's disease, Parkinsonism Relat Disord, 2013.

C. Rocha, M. Barbosa, and . Domperidone, QT Interval Prolongation Associated with the Oral Use of Domperidone in an Infant, Pediatric Cardiology, vol.289, issue.5, pp.720-723, 2005.
DOI : 10.1097/00005176-200211004-00001

J. Roy-desruisseaux, Domperidone-Induced Tardive Dyskinesia and Withdrawal Psychosis in an Elderly Woman with Dementia, Annals of Pharmacotherapy, vol.45, issue.9, p.51, 2011.
DOI : 10.1345/aph.1Q214

M. Sanklecha and V. Charde, Domperidone overdose Domperidone disaster: Need for a single formulation?, Indian Journal of Pediatrics, vol.80, issue.7, pp.1-615, 2013.
DOI : 10.1007/s12098-012-0891-9

URL : https://link.springer.com/content/pdf/10.1007%2Fs12098-012-0891-9.pdf

K. Smolina, B. Mintzes, and G. Hanley, The association between domperidone and ventricular arrhythmia in the postpartum period, Pharmacoepidemiology and Drug Safety, vol.6, issue.10, 2016.
DOI : 10.1111/j.1467-789X.2005.00199.x

P. Sol, B. Pelet, and J. Guignard, EXTRAPYRAMIDAL REACTIONS DUE TO DOMPERIDONE, The Lancet, vol.316, issue.8198, p.802, 1980.
DOI : 10.1016/S0140-6736(80)90415-8

D. Stork, . Timin, C. Berjukow, and . Huber, State dependent dissociation of HERG channel inhibitors, British Journal of Pharmacology, vol.84, issue.8, pp.1368-1376, 2007.
DOI : 10.1161/01.RES.84.9.989

C. Van-noord, J. Dieleman, G. Van-herpen, K. Verhamme, and M. Sturkenboom, Domperidone and Ventricular Arrhythmia or Sudden Cardiac Death, Drug Safety, vol.44, issue.6, pp.1003-1017, 2010.
DOI : 10.7326/0003-4819-119-10-199311150-00011

M. Vieira, Effects of domperidone on QTc interval in infants, Acta Paediatrica, vol.98, issue.Suppl 2, pp.494-496, 2012.
DOI : 10.1111/j.1651-2227.2008.01158.x

V. Matushka and N. , Clinical Research Report. A multicentre double-blind evaluation of domperidone in the treatment of postprandial dyspepsia, Janssen Clinical Research, 1979.

E. Wan, K. Davey, H. Madhu, E. Peter, and K. Simmer, Dose-effect study of domperidone as a galactagogue in preterm mothers with insufficient milk supply, and its transfer into milk, British Journal of Clinical Pharmacology, vol.102, issue.2
DOI : 10.1161/01.CIR.102.16.1883

T. Yoshizato, Itraconazole and domperidone: a placebo-controlled drug interaction study, European Journal of Clinical Pharmacology, vol.63, issue.9
DOI : 10.1007/s00228-007-0365-6